Company snapshot
Market Cap
$182B
Large-cap2016 — today
10-Year Price
+90%
2016 — today
52-Week Range
$110.56$155.80
Current $146.41· 79%
Featured in rankings
S&P500NASDAQBest Healthcare Dividend StocksMost Undervalued Dividend StocksBest High-Yield Dividend Stocks
Rankings recomputed after each US market close — see where GILD stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ABTAbbott Laboratories | 33.1 | 2.4% |
| NVONovo Nordisk A/S | 10.7 | 4.1% |
| AMGNAmgen Inc. | 23.7 | 2.6% |
| PFEPfizer Inc. | 36.6 | 6.2% |
| TMOThermo Fisher Scientific Inc. | 33.0 | 0.3% |
| DHRDanaher Corporation | 36.1 | 0.7% |
| ISRGIntuitive Surgical, Inc. | 43.0 | — |
| VRTXVertex Pharmaceuticals Incorporated | 30.2 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
-54.8
N/A
Not meaningful — company is unprofitable
Sector median 25.1below sector
P/B ratio
15.5
Near historic high
Near historic highs — last 10 years
Sector median 2.5above sector
EV / EBITDA
322.4
Near historic high
Near historic highs — last 10 years
Sector median 15.4above sector
Dividend Yield
2.2%
Near historic low
Near historic low — last 10 years
Sector median 1.7%above sector
FCF Yield
7.3%
Historically low
Historically low relative to the last 10 years
Sector median -10.1%above sector